BVF PARTNERS L P/IL - Director, 10%+ Owner at MoonLake Immunotherapeutics

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
MLTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by BVF PARTNERS L P/IL since 13 Feb 2025

Holdings reported by BVF PARTNERS L P/IL for MoonLake Immunotherapeutics

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Shares, $0.0001 par value 1,287,768 $51,742,518 $40.18 05 Jun 2025 Direct
Option to Buy 6,682 $268,482 $40.18 05 Jun 2025 Indirect Class A Ordinary Shares, $0.0001 par value 6,682
Class A Ordinary Shares, $0.0001 par value 1,420,317 06 Jun 2024 Direct

Transactions reported by BVF PARTNERS L P/IL for MoonLake Immunotherapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.